Literature DB >> 14176059

THE EFFECT OF PHENOTHIAZINES ON THE ELECTROCARDIOGRAM.

T A BAN, A STJEAN.   

Abstract

Thioridazine, chlorpromazine and trifluoperazine were administered to six psychiatric patients. Each was used in four dosage levels (thioridazine and chlorpromazine: 200, 400, 800 and 1200 mg. daily; trifluoperazine: 8, 16, 32, 64 mg. daily); and each increase in dosage was effected after four days of drug administration.Before the trial, twice during each drug period and before commencement of the next dose regimen, an electrocardiogram (ECG) was recorded. The findings indicated that thioridazine modifies the terminal portion (S-T segment, T and U waves) of the human ECG. A similar change occurred in three of six subjects while taking chlorpromazine and in one of six while taking trifluoperazine. Thioridazine induced changes in all six subjects studied, viz., blunting and notching of T waves with or without prolongation of QT interval. In some the notching produced a doublehump appearance in which a T wave of reduced voltage formed the proximal hump and a positive U wave of increased voltage formed the distal hump.Thioridazine-induced alterations in the ECG have been described as resembling those caused by quinidine; they also resemble changes associated with hypokalemia.

Entities:  

Keywords:  CHLORPROMAZINE; CLINICAL RESEARCH; ELECTROCARDIOGRAPHY; PHARMACOLOGY; SCHIZOPHRENIA; THIORIDAZINE; TOXICOLOGIC REPORT; TRIFLUOPERAZINE

Mesh:

Substances:

Year:  1964        PMID: 14176059      PMCID: PMC1927931     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  1 in total

1.  THIORIDAZINE HYDROCHLORIDE (MELLARIL): ITS EFFECT ON THE ELECTROCARDIOGRAM AND A REPORT OF TWO FATALITIES WITH ELECTROCARDIOGRAPHIC ABNORMALITIES.

Authors:  H G KELLY; J E FAY; S G LAVERTY
Journal:  Can Med Assoc J       Date:  1963-09-14       Impact factor: 8.262

  1 in total
  12 in total

1.  Arrhythmias and sudden death in patients taking antipsychotic drugs.

Authors:  Andrew Herxheimer; David Healy
Journal:  BMJ       Date:  2002-11-30

Review 2.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

3.  Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.

Authors:  Charles E Leonard; Cristin P Freeman; Craig W Newcomb; Warren B Bilker; Stephen E Kimmel; Brian L Strom; Sean Hennessy
Journal:  J Clin Exp Cardiolog       Date:  2013

4.  Phenothiazine induced ventricular tachycardia.

Authors:  T B Tri; D T Combs
Journal:  West J Med       Date:  1975-11

Review 5.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 6.  Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 7.  Ziprasidone in the management of schizophrenia : the QT interval issue in context.

Authors:  David Taylor
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Thioridazine and EKG anomalies.

Authors:  B Hine; L J Traficante; G Sakalis; S Gershon
Journal:  Experientia       Date:  1979-12-15

9.  Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule.

Authors:  G Chouinard; A M Ghadirian; B D Jones
Journal:  Can Med Assoc J       Date:  1978-10-07       Impact factor: 8.262

10.  Diagnosis and treatment of delirium.

Authors:  W D Henry; A M Mann
Journal:  Can Med Assoc J       Date:  1965-11-27       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.